miRNAs Can Affect Intestinal Epithelial Barrier in Inflammatory Bowel Disease

Front Immunol. 2022 Apr 13:13:868229. doi: 10.3389/fimmu.2022.868229. eCollection 2022.

Abstract

The most obvious pathological characterization of inflammatory bowel disease (IBD) is intestinal epithelium erosion and severe inflammation invasion. Micro-ribonucleic acids (miRNA or microRNA), single-stranded noncoding RNAs of ~22 nucleotides, have been considered as the potential therapeutic targets in the pathogenesis of IBD. Many previous studies have focused on the mechanisms that miRNAs use to regulate inflammation, immunity, and microorganisms in IBD. The review highlights in detail the findings of miRNAs in the intestinal epithelial barrier of IBD, and focuses on their gene targets, signaling pathways associated with IBD, and some potential therapies. It will be beneficial for the elucidation of the interaction between miRNAs and the intestinal epithelial barrier in IBD and provide a theoretical reference for preventing and treating IBD in the future.

Keywords: gene targets; inflammatory bowel disease; intestinal epithelial barrier; miRNA; signaling pathways.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Inflammation / metabolism
  • Inflammatory Bowel Diseases*
  • Intestinal Mucosa / metabolism
  • Intestines / pathology
  • MicroRNAs* / metabolism

Substances

  • MicroRNAs